AIM AND SCOPE
Journal of Genetic Disorders and Therapy (JGDT) aims at rapid publication of high-quality results in Genetic Disorders and Therapy while maintaining a rigorous peer-review process. All accepted papers will be appearing online immediately.
JGDT encourages submission of manuscripts related to (but not limited to) Genomics, Genetic diseases, Autosomal recessive diseases, Charcot-Marie-Tooth disease, Myotonic dystrophy, Tuberous sclerosis Diabetes, mellitus and deafness, Encephalomyopathy, Lactic acidosis, Leber hereditary, optic neuropathy, Leigh syndrome, Mitochondrial myopathy Publishing Areas:
- Gaucher's disease
- Glycogen storage diseases
- Niemann-Pick disease
- Sickle cell disease
- Spinal muscular atrophy
- Tay-Sachs disease
- Mutational analysis
- Computational genetics
- Regulation of gene expression
- Population genetics
- Chromosome biology
Publication of article types:
Original research articles: Describes original research within the scope of the journal.
Case reports: Reports of clinical presentations describing a diagnostic or therapeutic dilemma followed by evaluative studies
Editorial comments: Introduce current research and comment on major advances and developments in the field.
Methodology: Present a new experimental method, test or procedure. The methods described may be completely new or a better version of already existing one. The method should demonstrate all the possible tests and results.
Rapid communications: Short papers presenting highly significant and original material.
Review articles: To review the progression of a research in the field and make suggestions for future work includes authoritative, comprehensive, descriptions of any subject within the scope of Genetic Disorders and Therapy journal.
Letters to the editor: Letter consisting of comments directly on publications of journal which are already published or introduces a specific issue of general interest.
As the Journal of Genetic Disorders and Therapy research follows the Creative Commons Attribution License and scholars open access publishing policies, readers can freely access the published articles online and JGDT will be kept up to date with the latest advances in the field of Genetic Disorders and Therapy. All published articles will be assigned with a unique Digital Objective Identifier provided by Cross Ref.